For subscribers
Making Strides in Covid-19 battle
India's Strides Pharma, whose unit will make Russia's Sputnik V vaccine, is emblematic of the country's strengths in biomedical science
Sign up now: Get ST's newsletters delivered to your inbox
Strides Pharma Global CEO Mohan Kumar says the Sputnik V contract is a vote of trust in Strides as well as an endorsement of the capabilities of the Indian pharma industry.
ST PHOTO: KELVIN CHNG
Follow topic:
Unlike its giant outsourcing companies such as Tata Consultancy Services and Infosys Technologies, India's pharmaceutical makers are a lot less understated in their public profiles even as they are the No. 1 supplier of generics globally.
Those who know something of the industry would recognise Sun Pharma, Cipla and Dr Reddy's Laboratories as among the better known names in a highly fragmented space. In the first quarter of this year, one firm that caught global attention was Bangalore-based Strides Pharma Science.
